Allergy is a complex market in which people navigate both prescription and over-the-counter treatments, often moving between self-management and professional care. Yet traditional evidence sources rarely capture how treatment decisions are made in daily life, why symptoms persist, or what drives people to switch, combine, or discontinue therapies. This white paper explores how digital engagement with a free mobile app to manage chronic conditions can help pharmaceutical leaders better understand the real-world experience behind allergies. Drawing on insights from the Allergy Buddy app community, it examines: The prescription and OTC treatments people use in everyday settings Persistent symptoms and unmet needs despite treatment How seasonal and environmental factors affect behaviors The value of longitudinal patient-reported data can be offered to the industry, across Medical Affairs, Clinical Development, Commercial, Brand, and Patient Engagement teams Understand how digital patient engagement can support brand lifecycle strategy and turn real-world insights into actionable evidence to support more informed, patient-centered strategies in the allergy market. Offered by: Aptar Digital Health
